{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:35Z","timestamp":1787026655304,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The coexistence of psoriatic arthritis (PsA) with inflammatory myopathies, including antisynthetase syndrome (ASS), is exceptionally rare and presents significant diagnostic and therapeutic challenges. This study reports a case of PsA overlapping with ASS and reviews the literature to analyze clinical features, immunopathogenesis, and treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 52-year-old female with a 10-year history of psoriasis developed PsA and later presented with muscle weakness, mechanic\u2019s hands, and interstitial lung disease (ILD). Serological testing revealed anti-Jo-1 and anti-SSA\/Ro52 positivity, confirming ASS. We compare our case with 17 previously reported cases of psoriasis or PsA coexisting with inflammatory myopathies, highlighting similarities and differences in clinical presentation and treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Psoriasis and inflammatory myopathies share immunopathogenic pathways, including the IL-17\/IL-23 axis, type I interferons, and TNF-\u03b1. Therapies effective for psoriasis\/PsA, such as TNF and IL-17 inhibitors, may exacerbate inflammatory myopathies, while JAK inhibitors and corticosteroids appear more effective in managing overlap cases. Our patient achieved sustained remission with baricitinib and low-dose prednisone after multiple treatment adjustments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PsA and inflammatory myopathies can coexist, requiring careful differentiation and tailored immunomodulatory therapy. Clinicians should recognize overlapping features and optimize treatment to prevent exacerbations. Further research is needed to establish standardized management strategies for this rare overlap syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1626226","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:28:07Z","timestamp":1754630887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features and therapeutic challenges of psoriatic arthritis coexisting with antisynthetase syndrome: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Rui","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve May"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.15171\/ipp.2018.01","article-title":"Psoriasis with polymyositis; a rare combination of two autoimmune diseases","volume":"4","author":"Sofi","year":"2018","journal-title":"Immunopathol Persa"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165803","article-title":"Psoriasis and connective tissue diseases","volume":"21","author":"Toshiyuki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345646","article-title":"Concurrence of dermatomyositis and psoriasis: a case report and literature review","volume":"15","author":"Chu","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.1668","article-title":"Distinct histopathologic patterns of finger eruptions in dermatomyositis based on myositis-specific autoantibody profiles","volume":"155","author":"Okiyama","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez020","article-title":"Successful treatment of refractory mechanic\u2019s hands with ustekinumab in a patient with the antisynthetase syndrome","volume":"58","author":"Pinal-Fernandez","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15636","article-title":"Psoriasis vulgaris in a patient with antisynthetase syndrome","volume":"48","author":"Hanami","year":"2021","journal-title":"J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2298\/vsp0405557p","article-title":"Psoriasis in a patient with dermatomyositis","volume":"61","author":"Pavlovic","year":"2004","journal-title":"Vojnosanit Pregl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-31802010000500012","article-title":"Association of anti-glomerular basement membrane antibody disease with dermatomyositis and psoriasis: case report","volume":"128","author":"MaChado","year":"2010","journal-title":"Sao Paulo Med J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.49","article-title":"Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis","volume":"147","author":"Kim","year":"2011","journal-title":"Arch Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.11.012","article-title":"Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis","volume":"70","author":"Dicaro","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13265","article-title":"Association of psoriasis with Hashimoto\u2019s thyroiditis, Sjogren\u2019s syndrome and dermatomyositis","volume":"43","author":"Akiyama","year":"2016","journal-title":"J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13084","article-title":"Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease","volume":"20","author":"Kato","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5070\/D3238036019","article-title":"Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine","volume":"23","author":"Inkeles","year":"2017","journal-title":"Dermatol Online J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000430","article-title":"A rare case of amyopathic juvenile dermatomyositis associated with psoriasis successfully treated with ustekinumab","volume":"23","author":"Montoya","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12869","article-title":"Co-existence of Juvenile dermatomyositis and psoriasis vulgaris with fungal infection: A case report and literature review","volume":"18","author":"Xing","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211057702","article-title":"Overlap of psoriatic arthritis and dermatomyositis","volume":"9","author":"Schreiber","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.6011","article-title":"Association of treatment with secukinumab with exacerbation of dermatomyositis in a patient with psoriasis","volume":"158","author":"Perna","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/ki4jbt","article-title":"Treatment of refractory psoriasis with dermatomyositis using upadacitinib","volume":"42","author":"Xu","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.166","article-title":"Effective narrow-band UVB radiation therapy suppresses the IL-23\/IL-17 axis in normalized psoriasis plaques","volume":"130","author":"Johnson-Huang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B23","article-title":"Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis","volume":"37","author":"Silva","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1038\/s41598-018-23539-4","article-title":"Interleukin-23 as a therapeutic target for inflammatory myopathy","volume":"8","author":"Umezawa","year":"2018","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1316-7","article-title":"Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23812","article-title":"Frequency and spectrum of myopathies in patients with psoriasis","volume":"48","author":"Liewluck","year":"2013","journal-title":"Muscle Nerve"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/itt.S500811","article-title":"Increased risk of dermatomyositis in patients with psoriasis: A retrospective cohort study","volume":"14","author":"Chen","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2016.10.010","article-title":"Anti-MDA5 dermatomyositis mimicking psoriatic arthritis","volume":"14","author":"Cabezas-Rodr\u00edguez","year":"2018","journal-title":"Reumatol Clin"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20646.1","article-title":"Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies","volume":"8","author":"Okiyama","year":"2019","journal-title":"F1000Research"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:28:07Z","timestamp":1754630887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1626226"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1626226","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1626226"}}